Taurine reduces FK506-induced generation of ROS and activation of JNK and Bax in Madin Darby canine kidney cells

Abstract

The immunosuppressive compound FK506 has been successfully used in kidney and liver transplant recipients. However, the compound can induce significant side effects on kidney function. Taurine is a potent free radical scavenger that attenuates a variety of renal diseases that are the consequence of excessive oxygen free radical damage. The purpose of this study was to investigate FK506-mediated death of Madin Darby canine kidney (MDCK) cells, in relation to reactive oxygen species (ROS) production. We determined the calcium (Ca²⁺) and magnesium (Mg²⁺) concentration in cultured MDCK cells by microfluorescence techniques and the level of activation of c-Jun-N-terminal kinase (JNK), extracellular signal regulated kinases (ERK), Bcl-2 and Bax proteins by Western blot. Treatment with 10 μM FK506 induced apoptosis in MDCK cells by increasing the level of intracellular ROS and Ca²⁺ and by decreaseing the level of intracellular Mg²⁺. This increase in intracellular ROS promoted JNK and Bax activation, which increased FK506-induced MDCK cell death. Taurine reduced the FK506-induced generation of ROS and activation of JNK and Bax. The results indicate that taurine can prevent FK506-induced kidney toxicity.

Keywords

MDCK cells FK506 taurine ROS JNK

References

Tocci MJ , Collier KA The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718-726.

Henry ML Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles . Clin Transplant 1999; 13: 209-220.

Mattos AM , Olyaei AJ , Bennett WM Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 2000; 35: 333-346.

Gonin JM Maintenance immunosuppression: New agents and persistent dilemmas. Adv Ren Replace Ther 2000; 7: 95-116.

Zhou X. , Yang G. , Hristopher AD , et al. Hydrogen peroxide mediates FK506-induced cytotoxicityin renal cells. Kidney International 2004; 65: 139-147.

Haberland A. , Henke W. , Grune T. Differential response of oxygen radical metabolism in rat heart, liver and kidney to cyclosporine: a treatment. Inflamm Res 1997; 46: 452-454.

Sturman JA , Hayes KC The biology of taurine in nutrition and development. Adv Nutri Res 1980; 3: 231-299.

Trachtman H. , Pizzo R. , Futterweit S. , et al. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol 1992; 262: F117-F123.

Trachtman H. , Futterweit S. , Maesaka J. , et al. Taurine ameliorates chronic streptozocin- induced diabetic nephropathy in rats. Am J Physiol 1995; 269: F429- F438.

10.

Buttke TM , Sandstrom PM Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.

11.

Ichijo H. , Nishida E. , Irie K. , et al. Induction of apoptosis by ASK1, a mammalian MAPK that activates SAPK/ JNK and p38 signaling pathways. Science 1997; 275: 90-94.

12.

Li D. , Ueta E. , Kimura T. , Yamamoto T. , Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004; 95: 644-650.

13.

Danial NN , Korsmeyer SJ Cell death: critical control points. Cell 2004; 116: 205-219.

14.

Erdem A. , Gundogan NU , Usubutun A. , et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transplant 2000; 15: 1175-1182.

15.

Jeon SH , Lee MY , Kim SJ , et al. Taurine increases cell proliferation and generates an increase in [Mg2+]i accompanied by ERK 1/2 activation in human osteoblast cells. FEBS Letters 2007; 581: 5929-5934.

16.

Lang F. , Busch GL , Volkl H. The diversity of volume regulatory mechanisms. Cell Physiol Biochem 1988; 8: 1-45.

17.

Wu QD , Wang JH , Fennessy F. , Redmond HP , Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis . Am J Physiol 1999; 277: C1229-C1238.